SYMBOL
LAST
CHANGE
BID
ASK
VOLUME
{{ShareDataCollection.symbol}}
{{ShareDataCollection.lastTrade}}
{{ShareDataCollection.changePercent}}
{{ShareDataCollection.bid}}
{{ShareDataCollection.askSize}}
{{ShareDataCollection.volume}}

Share Data



As of 31 December 2021, the issued ordinary share capital is 584,908,239
As of 31 December 2021, the number of ADSs outstanding is 116,495,802
These figures may have changed since.

SEC Filings

Filter by form type

caret
  • All
  • {{Category}}
Filing Date
Form Type
Description
Filing Group
Downloads
{{format_date(Info.filingDate)}}
{{Info.formType}}
{{Info.description}}

Whistleblower Services

Confidential and anonymous financial concern hotline

The SEC, in its final ruling regarding standards relating to Audit Committees, requires that Mereo BioPharma Group plc provide a facility for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters.

Please feel free to contribute any comments through the interface linked to below regarding such accounting matters. Your message is encrypted and will be delivered directly to the Audit Committee.

https://www.whistleblowerservices.com/mreo/